The estimated Net Worth of James Edeerfield Management... is at least $8.85 Million dollars as of 15 July 2024. James Management owns over 11,766,000 units of BiomX Inc stock worth over $8,848,669 and over the last few years James sold PHGE stock worth over $0.
James has made over 1 trades of the BiomX Inc stock since 2024, according to the Form 4 filled with the SEC. Most recently James exercised 11,766,000 units of PHGE stock worth $11,648,340 on 15 July 2024.
The largest trade James's ever made was exercising 11,766,000 units of BiomX Inc stock on 15 July 2024 worth over $11,648,340. On average, James trades about 3,922,000 units every 0 days since 2024. As of 15 July 2024 James still owns at least 8,938,049 units of BiomX Inc stock.
You can see the complete history of James Management stock trades at the bottom of the page.
Over the last 5 years, insiders at BiomX Inc have traded over $332,366 worth of BiomX Inc stock and bought 1,036,414 units worth $787,614 . The most active insiders traders include James Edeerfield Management..., Chidozie Ugwumba, and Erez Chimovits. On average, BiomX Inc executives and independent directors trade stock every 68 days with the average trade being worth of $533,749. The most recent stock trade was executed by James Edeerfield Management... on 15 July 2024, trading 11,766,000 units of PHGE stock currently worth $11,648,340.
biomx is a microbiome drug discovery company developing customized phage therapies that target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease (ibd) and cancer. we discover and validate proprietary bacterial targets and customize our natural and engineered phage compositions against these targets. the company’s platforms use computational and synthetic biology and cutting-edge research from profs. rotem sorek, ph.d., eran elinav, m.d., ph.d., and eran segal, ph.d., of the weizmann institute of science; and professor timothy k. lu, m.d., ph.d., of the massachusetts institute of technology. investors in the company include orbimed israel incubator lp, johnson & johnson development corporation inc., takeda ventures, inc., seventure partners, mirae asset global investments, and sbi.
BiomX Inc executives and other stock owners filed with the SEC include: